Brendan Smith on LinkedIn: Today, CRISPR Therapeutics and ViaCyte announced that Health Canada
CRISPR Therapeutics and ViaCyte, Inc. to Start Clinical
Pin on Diabetes
ViaCyte Announces Second Clinical Trial Site at University of Alberta
CRISPR and ViaCyte dose first subject in Phase I T1D therapy trial
First Patient Dosed in Phase 1 Clinical Trial for T1D | The Stem Cellar
JDRF Partner ViaCyte to Immediately Initiate Type 1 Diabetes Clinical Trial — Juicebox Podcast and Arden's Day
First Human Clinical Trial of Stem Cell-Derived Implants For Type 1 Diabetes
Finally, a possible long-term treatment for type 1 diabetes | UCI Health | Orange County, CA
ViaCyte closes $45M financing for stem cell-derived type 1 diabetes therapies - Drug Delivery Business
Product Pipeline for Insulin-Requiring Diabetes Treatments
CIRM-supported Type I Diabetes treatment enters clinical trials in Europe | The Stem Cellar
Practical Cure Project Update: ViaCyte — Juvenile Diabetes Cure Alliance
Xconomy: ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics
CRISPR Therapeutics and ViaCyte, Inc. Announce First Patient Dosed in Phase 1 Clinical Trial of Novel Gene-Edited Cell Replacement Therapy for Treatment of Type 1 Diabetes (T1D)
Clinical trials of stem cell-based "functional cure" for type 1 diabetes underway
ViaCyte - Posts | Facebook
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient - The Niche
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
Product Pipeline for Insulin-Requiring Diabetes Treatments
ViaCyte (@ViaCyte) / Twitter
ViaCyte on Twitter: "Nov. 6: ViaCyte VP, Research and CSO Kevin D'Amour to speak at @ISSCR's “From Stem Cell Biology to New Therapies” https://t.co/f8anGrT6wi #ISSCR #biotech #Toronto #health #T1D #type1diabetes #diabetes #regenerativemedicine #
Diabetes Device Engineering | Implanting Cell Replacement Therapies
Breakthrough Technologies for Cell Replacement Therapies for Diabetes| ViaCyte
Stem cell therapies for Type 1 diabetes: current status and proposed road map to guide successful clinical trials - Senior - 2019 - Diabetic Medicine - Wiley Online Library
ViaCyte's Stem Cell-Derived Treatment for Type 1 Diabetes Shows Promising Results in Two Published Studies - ViaCyte
